Arnt Schellekens - Dissemin

Papers authored by Arnt Schellekens

This paper was not found in any repository, but could be made available legally by the author.

2018 I. D. Munsterman, M. M. Groefsema, G. Weijers, W. M. Klein, D. W. Swinkels, J. P. H. Drenth, A. F. A. Schellekens

, E. T. T. L. Tjwa

Biochemical Effects on the Liver of 1 Month of Alcohol Abstinence in Moderate Alcohol Consumers

Upload

This paper is made freely available by the publisher.

Harmen Beurmanjer

, Rama M. Kamal, Cor A. J. de Jong, Boukje A. G. Dijkstra, Arnt F. A. Schellekens

Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

L. VandeWijer, D. N. Mchaile, A. F. A. Schellekens

, N. N. J. Lambregts-Rommelse, Q. de Mast, B. T. Mmbaga, A. J. A. M. van derVen, G. D. Kinabo

Central nervous system toxicity of efavirenz in HIV-infected children in Tanzania

Upload

Reinier L. Sluiter, Wietske Kievit, Gert Jan van der Wilt, Aart H. Schene, Martina Teichert, Marieke J. H. Coenen

, Arnt Schellekens

Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach

Upload

Cleo L. Crunelle, Wim van den Brink, Franz Moggi, Maija Konstenius, Johan Franck, Frances R. Levin, Geurt van de Glind, Zsolt Demetrovics, Corne Coetzee, Mathias Luderer, Arnt Schellekens

, Frieda Matthys

International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder

Download from www.karger.com

2017 Marion Sumari-De Boer, Marion Sumari de Boer, Arnt Schellekens

, Ashanti Duinmaijer, Julieth M. Lalashowi, Happiness J. Swai, Quirijn de Mast

, Andre van der Ven, Grace Kinabo

Upload

Joanne E. L. VanDerNagel, Neomi van Duijvenbode, Stephen Ruedrich, Astri P. Ayu, Arnt F. A. Schellekens

The Perception of Substance Use Disorder Among Clinicians, Caregivers and Family Members of Individuals With Intellectual and Developmental Disabilities

Upload

Lisa Van de Wijer, Grace D. Kinabo, Deborah N. Mchaile, Quirijn de Mast

, Arnt F. A. Schellekens

, André J. A. M. van der Ven

Safety Evaluation of Efavirenz in Children: Don’t Forget the Central Nervous System

Upload

M. Luijten, A. F. Schellekens

, S. Kühn, M. W. J. Machielse, G. Sescousse

Disruption of reward-processing in addiction unravelled by image based meta-analysis of fMRI studies

Upload

Albert Batalla, Judith R. Homberg, Tatiana V. Lipina, Guillaume Sescousse, Maartje Luijten, Svetlana A. Ivanova, Arnt F. A. Schellekens

, Anton J. M. Loonen

The role of the habenula in the transition from reward to misery in substance use and mood disorders

Upload

This paper is available in a repository.

Astri Parawita Ayu, Nady el-Guebaly, Arnt Schellekens

, Cor De Jong

, Gabrielle Welle-Strand, William Small, Evan Wood, Walter Cullen, Jan Klimas

Core addiction medicine competencies for doctors: An international consultation on training

Download from hdl.handle.net

K. Mann, F. Kiefer, A. Schellekens

, G. Dom

Behavioural addictions: Classification and consequences

Download from doi.org

Arnt F. Schellekens

, Maartje Luijten, Guillaume Sescousse

Are There Differences in Disruptions of Reward Processing Between Substance Use Disorder and Gambling Disorder?—Reply

Upload

A. Schellekens

Staging & profiling in addiction, can we cross the gap from bench to bedside?

Download from doi.org

Lisa C. Martial, Rob E. Aarnoutse, Martina Mulder, Arnt Schellekens

, Roger J. M. Brüggemann, David M. Burger, Aart H. Schene, Albert Batalla

Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring

Upload

GianLuca Quaglio, Arnt Schellekens

, Matthijs Blankers, Eva Hoch, Theodoros Karapiperis, Giovanni Esposito, Helmut Brand

, David Nutt, Falk Kiefer

A Brief Outline of the Use of New Technologies for Treating Substance Use Disorders in the European Union

Upload

Rama M. Kamal, Martijn S. van Noorden, M. S. van Noorden, Wim Wannet, Harmen Beurmanjer, Boukje A. G. Dijkstra, Arnt F. A. Schellekens

Pharmacological treatment in gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) dependence: Detoxification and relapse prevention

Upload

Distributing this paper is prohibited by the publisher

Maartje Luijten, Arnt F. Schellekens

, Simone Kühn, Marise W. J. Machielse, Guillaume Sescousse

Disruption of Reward Processing in Addiction

Upload

2016 Bas T. H. de Veen, Arnt F. A. Schellekens

, Michel M. M. Verheij, Judith R. Homberg

Psilocybin for treating substance use disorders?

Download from repository.ubn.ru.nl

Lisa Van de Wijer, Arnt F. A. Schellekens

, David M. Burger, Judith R. Homberg, Quirijn de Mast

, Andre J. A. M. van der Ven

Rethinking the risk–benefit ratio of efavirenz in HIV-infected children

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Arnt Schellekens